Published in J Antimicrob Chemother on October 01, 1986
RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases. Antimicrob Agents Chemother (2003) 0.96
Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan. Epidemiol Infect (1988) 0.95
In vitro activity of the tricyclic beta-lactam GV104326. Antimicrob Agents Chemother (1996) 0.86
The emergence of antibiotic resistance: myths and facts in clinical practice. Intensive Care Med (1990) 0.79
A regional survey of the resistance to beta-lactam antibiotics in clinical isolates of (facultative) aerobic micro-organisms. Drugs (1988) 0.75
Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J Infect Dis (1971) 3.76
Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet (1975) 3.34
Vacuum blood-culture bottles inhibiting growth of Candida and fostering growth of Bacteroides. Lancet (1974) 3.26
Molecular epidemiology of antibiotic resistance in salmonella from animals and human beings in the United States. N Engl J Med (1982) 2.97
The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med (1990) 2.40
The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29
Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol (1999) 2.14
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrob Agents Chemother (1981) 1.81
Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother (1980) 1.79
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance. Diagn Microbiol Infect Dis (1992) 1.74
Broad-spectrum, transmissible beta-lactamases. N Engl J Med (1988) 1.70
Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis (1997) 1.61
Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J Infect Dis (1987) 1.60
Computer-generated plots of results of antimicrobial-susceptibility tests. JAMA (1969) 1.58
Recent experience with bacillemia due to gram-negative organisms. J Infect Dis (1971) 1.50
Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid. Science (1985) 1.43
The Holy Cross college football team hepatitis outbreak. JAMA (1972) 1.42
International comparison of prevalence of resistance to antibiotics. JAMA (1978) 1.34
Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae. J Infect Dis (1976) 1.27
Automated use of WHONET and SaTScan to detect outbreaks of Shigella spp. using antimicrobial resistance phenotypes. Epidemiol Infect (2009) 1.19
Resistance of bacteria to antibacterial agents: report of Task Force 2. Rev Infect Dis (1987) 1.18
Gly-238-Ser substitution changes the substrate specificity of the SHV class A beta-lactamases. Proteins (1991) 1.17
Trimethoprim resistance in multiple genera of Enterobacteriaceae at a U.S. hospital: spread of the type II dihydrofolate reductase gene by a single plasmid. J Infect Dis (1985) 1.13
Bacterial infection in renal homotransplant recipients. A study of fifty-three bacteremic episodes. Am J Med (1972) 1.11
Beta-lactamase effect on ampicillin treatment of Haemophilus influenzae B bacteremia and meningitis in infant rats. Antimicrob Agents Chemother (1977) 1.11
DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol (1995) 1.10
Global surveillance of antibiotic resistance. N Engl J Med (1992) 1.09
Antibiotic resistance. Epidemiology and therapeutics. Diagn Microbiol Infect Dis (1992) 1.09
Listeroisis in immunosuppressed patients. A cluster of eight cases. Am J Med (1975) 1.08
Phycomycotic gangrenous cellulitis. A report of two cases and a review of the literature. Arch Surg (1976) 1.03
R factor-mediated increments in levels of resistance to and enzymatic degradation of penicillins and cephalosporins. Antimicrob Agents Chemother (Bethesda) (1967) 1.02
Association of cephalosporinase activity, cephalothin resistance, and episome-mediated drug resistance in Klebsiella strains. Antimicrob Agents Chemother (Bethesda) (1966) 0.99
Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1974) 0.98
Lower esophageal sphincter pressure (LESP) and esophageal function in obese humans. J Clin Gastroenterol (1980) 0.98
Contribution of R factors to the antibiotic resistance of hospital isolates of Serratia. Antimicrob Agents Chemother (Bethesda) (1968) 0.97
Severe pneumonia in renal transplant patients. One year's experience. Ann Intern Med (1971) 0.94
Boundaries during normal and abnormal brain development: in vivo and in vitro studies of glia and glycoconjugates. Exp Neurol (1990) 0.93
Hemangioblastoma of the radial nerve: case report. Neurosurgery (1995) 0.93
Detection and surveillance of antimicrobial resistance. Trends Microbiol (1994) 0.92
Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides. Rev Infect Dis (1982) 0.91
International surveillance of prevalence of antibiotic resistance. J Antimicrob Chemother (1977) 0.90
Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid. Antimicrob Agents Chemother (1991) 0.90
Encephalopathy due to capillary leak syndrome. South Med J (1997) 0.88
Molecular evolution, species distribution, and clinical consequences of an endemic aminoglycoside resistance plasmid. Antimicrob Agents Chemother (1986) 0.87
Australia antigen serology in the Holy Cross football team hepatitis outbreak. Lancet (1970) 0.86
Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg (1995) 0.86
The Holy Cross hepatitis outbreak: clinical and chemical abnormalities. Arch Intern Med (1972) 0.85
The epidemiology of bacterial resistance to quinolones. Drugs (1993) 0.85
Prophylactic hemodialysis in the treatment of acute renal failure. Annals of Internal Medicine, 53:992-1016, 1960. J Am Soc Nephrol (1998) 0.84
Glycoconjugate boundaries during early postnatal development of the neostriatal mosaic. J Comp Neurol (1988) 0.84
Computer surveillance of shifts in the gross patient flora during hospitalization. J Infect Dis (1975) 0.83
Functional and structural map of pLST1000: a multiresistance plasmid widely distributed in Enterobacteriaceae. Plasmid (1988) 0.81
Abnormal glial and glycoconjugate dispositions in the somatosensory cortical barrel field of the early postnatal reeler mutant mouse. Brain Res (1987) 0.79
Gastric cytology: evaluation of methods and results in 1,670 cases. Acta Cytol (1969) 0.79
Genetic and physical characterization of IncM plasmid pBWH1 and its variance among natural isolates. J Bacteriol (1986) 0.79
Diagnostic microbiology laboratory susceptibility test results discriminate distinctive antibiotic resistance plasmids. Diagn Microbiol Infect Dis (1984) 0.79
"Pseudostone" of the gallbladder. Ultrasound findings and case report. Gastroenterology (1977) 0.79
Neuron-glial interactions during the in vivo and in vitro development of the nigrostriatal circuit. J Chem Neuroanat (1993) 0.78
Urinary tract infections in an American rehabilitation hospital. J Hosp Infect (1984) 0.78
Solitary focal demyelination in the brain as a paraneoplastic disorder. Med Pediatr Oncol (1996) 0.78
Demyelination in the brain as a paraneoplastic disorder: candidates include some cases of seminoma and central nervous system lymphoma. J Neurol Neurosurg Psychiatry (2002) 0.78
Typhoid cholecystitis and gallbladder carcinoma after interval of 67 years. JAMA (1971) 0.78
Resistance to antibiotics in clinical isolates of Klebsiella pneumoniae. Infect Control (1985) 0.77
Boundary molecules during brain development, injury, and persistent neurogenesis--in vivo and in vitro studies. Prog Brain Res (1998) 0.77
Revisiting the Holy Cross football team hepatitis outbreak (1969) by serological analysis. JAMA (1985) 0.76
Thermophilic sporeforming bacilli that mimic fastidious growth characteristics and colonial morphology of legionella. J Clin Microbiol (1981) 0.76
Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South Med J (1983) 0.76
Expert medical witnesses. N C Med J (1989) 0.75
Diagnostic uses of immunology. Med Clin North Am (1965) 0.75
New concepts in medical bacteriology. J Med (1983) 0.75
Basal and maximally stimulated acid secretion in obese humans. J Clin Gastroenterol (1982) 0.75
Starch blockers. J Clin Gastroenterol (1983) 0.75
Unusual echographic appearance of a Courvoisier gall bladder. J Clin Ultrasound (1977) 0.75
Diagnosis of the Zollinger-Ellison syndrome in a patient with subtotal gastrectomy. Va Med Mon (1918) (1966) 0.75
Hepatitis secondary to pyrazinamide toxicity: accompaniments of transient hypolipoproteinemia, acanthocytosis, and changes in stomach and small bowel. South Med J (1970) 0.75
A risk management checklist. For academic and complex community medical centers. N C Med J (1989) 0.75
Holy Cross football team hepatitis outbreak. Antimicrob Agents Chemother (Bethesda) (1970) 0.75
Infection control surveillance in a rehabilitation hospital. Arch Phys Med Rehabil (1984) 0.75
Replicate inoculation of multi-chambered trays. Lab Pract (1970) 0.75
Differential diagnosis of intrahepatic shadowing on ultrasound examination. J Clin Ultrasound (1978) 0.75
Pernicious anemia with atrophic gastritis in a 17 year old boy. South Med J (1970) 0.75